Hide Board Information

Show Board Information

Genco Shipping & Trading Ltd. GNK

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/20/2023 5:15:12 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 13

Genco Shipping & Trading Ltd. (OTCMRKTS: GNK) Stock Message Board

1. GNK Company Profile

    

2. GNK Time & Sales

    

3. GNK Recent News

    

4. GNK Filings

    

5. GNK Financials

    

6. GNK Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

12	$GNK News Article - Genco Shipping & Trading	whytestocks	10/05/2023 1:20:47 PM
11	$GNK News Article - Sidoti's September Small-Cap	whytestocks	09/20/2022 3:00:47 PM
10	$GNK News Article - Genco Shipping & Trading	whytestocks	07/18/2022 1:56:06 PM
9	$GNK News Article - Genco Shipping (GNK) -	whytestocks	02/25/2022 2:55:50 PM
8	$GNK News Article - Genco Shipping (GNK) -	whytestocks	01/28/2022 8:05:48 AM
7	$GNK News Article - Genco Shipping & Trading	whytestocks	05/19/2021 8:50:51 AM
6	$GNK News Article - Genco Shipping & Trading	whytestocks	04/21/2021 10:39:47 AM
5	$GNK News Article - Genco Shipping and Trading	whytestocks	04/20/2021 8:10:55 AM
4	$GNK News Article - Genco Shipping & Trading	whytestocks	11/18/2020 2:10:48 PM
3	$GNK News Article - Why Shares of C.H. Robinson	whytestocks	07/29/2020 4:00:46 PM
2	$GNK News Article - Genco Shipping & Trading	whytestocks	10/24/2019 8:45:43 AM
1	$GNK News Article - Genco Shipping & Trading	whytestocks	05/08/2019 4:40:40 PM

Newer

Recent Articles

• U.S. Dollar Stabilizes Amid Consistent Tariff Discussions
• Investigation into Discover Financial Services Sale Process
• Investors Rally to Take Action Against TMC the Metals Company
• Celebrating Alumni Success at the Golden Globe Awards 2025
• BE Resources Stops Plans for Merger with Bio Graphene Solutions
• Williams Secures $1.5 Billion in Senior Notes Offering
• Wolfspeed Investors Urged to Act Before Upcoming Deadline
• Melania Trump Embraces Elon Musk as a Positive Presence
• Investigating MGO Global Inc.: Merger Insights and Implications
• MGP Ingredients Faces Class Action: Shareholders Should Act Now
• Elon Musk's Provocative Poll Sparks Debate in Global Politics
• UK Retail Sales Experience a Boost from Black Friday
• Icahn Enterprises Targets CVR Energy with Extended Offer
• Nvidia's Jensen Huang to Lead Keynote at CES Following Success
• Growth Projections for the Global Liquid Soap Market
• Investigation into Altair Engineering's Acquisition Deal
• Investigation into Sandy Spring Bancorp's Sale Process Overview
• Understanding the Proposed Sale of First of Long Island Corp
• Inari Medical, Inc. Stock Sale Review: Shareholder Rights at Stake
• Class Action Lawsuit Update for APLT Investors: Key Insights
• Yaber Unveils Innovative Projectors to Enhance Movie Nights
• Explore Yaber's Next-Gen Projectors Unveiled at CES 2025
• SAExploration Enhances Global Services with inApril Acquisition
• Jacobio Pharma Unveils Promising Glecirasib Data in Research
• Phillips 66 Expands Footprint with $2.2 Billion EPIC Acquisition
• Nippon Steel and U.S. Steel's Legal Challenge: A New Hope
• McDonald's Changes Course on Diversity Practices Amid Pressure
• Exciting Transition for QXO Shares to NYSE Trading
• Stage Front Tickets Welcomes Rob McFeaters as New CIO
• Tampa General Hospital Welcomes Melissa Golombek as COO
• Icahn Enterprises Extends Tender Offer for CVR Energy Shares
• Unleashing Power: MAINGEAR's New Signature Gaming Desktops
• Unveiling Health Innovations: Zepp Health at CES 2024 Events
• Candid Therapeutics Partners with WuXi Biologics for TCE Advancements
• Understanding Your Rights as Capri Holdings Stockholder
• Serko and Sabre Forge New Paths in Business Travel Solutions
• Investigation into Cara Therapeutics Merger Raises Concerns
• Legal Inquiry Into Potential Adams Resources Sale Price
• Investigation into Avid Bioservices Sale: Ensuring Fair Value
• Norgine Advances Eflornithine Application for High-Risk Patients
• Lucid Gravity SUV: A Leap Forward with Panasonic's Battery Tech
• Norgine Advances Eflornithine for Managing Neuroblastoma Risks
• Lead the Charge: Participate in Applied Therapeutics Lawsuit
• Adcentrx Therapeutics Takes Major Step with ADRX-0405 Trial Initiation
• WuXi Biologics Partners with Candid for Innovative Therapies
• Introducing Zepp Clarity's Innovative Hearing Aid Initiative
• Amazfit Active 2: Stylish Smartwatch for Health Enthusiasts
• Boeing Continues Culture Change Journey Post-737 MAX Incident
• Blinken's Japan Visits Amidst Nippon Steel Controversy
• Nvidia Soars as Tech Stocks Lift Wall Street Indexes